IRB Barcelona Nets $1.3M to Fuel Cancer Dx, Bioinformatics Spinoffs | GenomeWeb

NEW YORK (GenomeWeb News) – The Botin Foundation of Madrid has awarded €1 million ($1.3 million) to fund two technology spin-off initiatives at the Institute for Research in Biomedicine, Barcelona, including projects that will develop and seek to commercialize a test for colon cancer metastasis and a bioinformatics platform for simulating new drug designs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.